secwatch.observer — SEC 8-K summary
======================================

Issuer:     LEMAITRE VASCULAR INC (LMAT)
CIK:        0001158895
Form:       8-K
Filed at:   2024-02-27T23:59:59+00:00
Accession:  0001437749-24-005732
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

LeMaitre Q4 sales $48.9M (+19%), EPS $0.38 (+49%); declares $0.16 dividend, $50M buyback
--------------------------------------------------------------------------------

- Q4 2023 sales $48.9M (+19% YoY), net income $8.5M (+50%), EPS $0.38 (+49%).
- Gross margin 68.1% (+450 bps) driven by ASP increases and manufacturing efficiencies.
- Segment highlights: allografts +52%, bovine patches +18%, EMEA sales +21%.
- Full year 2024 guidance: sales $209.7-$214.3M (midpoint +10%), EPS $1.60-$1.71.
- Board declares $0.16/share dividend (payable Mar 28) and authorizes $50M share buyback.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1158895/000143774924005732/0001437749-24-005732-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1158895/000143774924005732/lmat20240227_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-005732

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer